| Literature DB >> 34884334 |
Michalis Panteli1,2,3, James S H Vun1,2,3, Robert M West4, Anthony J Howard1,2,3, Ippokratis Pountos1,2, Peter V Giannoudis1,2,3,5.
Abstract
BACKGROUND: Our objective was to develop and validate a predictive model for non-union following a subtrochanteric fracture of the femur.Entities:
Keywords: femur; non-union; risk factors; scoring system; subtrochanteric
Year: 2021 PMID: 34884334 PMCID: PMC8658386 DOI: 10.3390/jcm10235632
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Table presenting the demographics/characteristics of patients having their operation in our institution, with complete follow-up, stratified according to the progression to a non-union.
|
|
|
|
| |
| N | 316 | 232 (73.4%) | 84 (24.6%) | |
| Age (y.o.) | 69.13 ± 20.01 | 69.48 ± 20.81 | 68.18 ± 17.70 | |
| Gender | Male | 126 (39.9%) | 92 (39.7%) | 34 (40.5%) |
| Female | 190 (60.1%) | 140 (60.3%) | 50 (59.5%) | |
|
|
|
|
| |
| Mechanism of Injury | Low energy | 237 (75.0%) | 178 (76.7%) | 59 (70.2%) |
| High energy | 65 (20.6%) | 47 (20.3%) | 18 (21.4%) | |
| Pathological | 14 (0.4%) | 7 (3.0%) | 7 (8.3%) | |
| Isolated | 264 (83.5%) | 191 (82.3%) | 73 (86.9%) | |
| ISS > 16 | 25 (7.9%) | 17 (7.3%) | 8 (9.5%) | |
| Side | Left | 161 (50.9%) | 116 (50.0%) | 45 (53.6%) |
| Right | 155 (49.1%) | 116 (50.0%) | 39 (46.4%) | |
| Open fracture | 7 (2.2%) | 4 (1.7%) | 3 (3.6%) | |
|
|
|
|
| |
| ASA | 1 | 40 (12.7%) | 35 (15.1%) | 5 (6.0%) |
| 2 | 92 (29.1%) | 64 (27.6%) | 28 (33.3%) | |
| 3 | 149 (47.2%) | 107 (46.1%) | 42 (50.0%) | |
| 4 | 35 (11.0%) | 26 (11.2%) | 9 (10.7%) | |
| Charlson Comorbidity Score | 4.614 ± 3.04 | 4.56 ± 3.03 | 4.76 ± 3.06 | |
| Diabetes | 42 (13.3%) | 25 (10.8%) | 17 (20.2%) | |
| Steroids | 14 (4.4%) | 10 (4.3%) | 4 (4.8%) | |
| Malignancy | 69 (21.8%) | 48 (20.7%) | 21 (25.0%) | |
| Dementia | 39 (12.3%) | 34 (14.7%) | 5 (6.0%) | |
|
|
|
|
| |
| Bisphosphonates pre-admission | 60 (19.0%) | 40 (17.2%) | 20 (23.8%) | |
| Bisphosphonates on discharge | 86 (27.4%) | 63 (27.2%) | 23 (28.0%) | |
| Calcium/Vitamin D pre-admission | 83 (26.3%) | 58 (25.0%) | 25 (29.8%) | |
| Calcium/Vitamin D on discharge | 142 (45.2%) | 103 (44.4%) | 39 (47.6%) | |
| Vitamin D loading on admission | 42 (13.4%) | 34 (14.7%) | 8 (9.8%) | |
| Fragility Fractures Before | 56 (17.8%) | 40 (17.2%) | 16 (19.3%) | |
| Fragility Fractures After | 62 (19.9%) | 44 (19.0%) | 18 (21.7%) | |
| DEXA Result | Normal | 5 (12.5%) | 3 (10.3%) | 2 (18.2%) |
| Osteopenia | 13 (32.5%) | 7 (24.1%) | 6 (54.5%) | |
| Osteoporosis | 22 (55.0%) | 19 (65.5%) | 3 (27.3%) | |
| Singh Index | 1 | 24 (8.4%) | 18 (8.5%) | 6 (8.2%) |
| 2 | 61 (21.4%) | 48 (22.6%) | 13 (17.8%) | |
| 3 | 56 (19.6%) | 41 (19.3%) | 15 (20.5%) | |
| 4 | 66 (23.2%) | 48 (22.6%) | 18 (24.7%) | |
| 5 | 33 (11.6%) | 22 (10.4%) | 11 (15.1%) | |
| 6 | 45 (15.8%) | 35 (16.5%) | 10 (13.7%) | |
|
|
|
|
| |
| Smoking | 68 (21.5%) | 49 (21.1%) | 19 (22.6%) | |
| Alcohol > 10 units/week | 67 (21.2%) | 44 (19.0%) | 23 (27.4%) | |
| Pre-operative Mobility | ||||
| Independent | 174 (55.1%) | 129 (55.6%) | 45 (53.6%) | |
| Stick(s)/Crutch(es) | 94 (29.7%) | 62 (26.7%) | 32 (38.1%) | |
| Frame | 35 (11.1%) | 30 (12.9%) | 5 (6.0%) | |
| Wheelchair/Hoisted | 13 (4.1%) | 11 (4.7%) | 2 (2.4%) | |
| Frequent falls | 80 (25.3%) | 61 (26.3%) | 19 (22.6%) | |
|
|
|
|
| |
| Operation in less than 48 h | 247 (78.2%) | 182 (78.4%) | 65 (77.4%) | |
| Simultaneous procedures | 27 (8.5%) | 22 (9.5%) | 5 (6.0%) | |
| Type of Nail | Long Affixus Nail | 160 (50.6%) | 124 (53.4%) | 36 (42.9%) |
| Long Gamma Nail | 128 (40.5%) | 90 (38.8%) | 38 (45.2%) | |
| Others | 28 (8.9%) | 18 (7.8%) | 10 (11.9%) | |
| Nail Diameter | 9 | 18 (5.8%) | 9 (3.9%) | 9 (10.8%) |
| (mm) | 10 | 7 (2.1%) | 4 (1.7%) | 3 (3.6%) |
| 11 | 203 (64.9%) | 154 (67.0%) | 49 (59.0%) | |
| 13 | 85 (27.2%) | 63 (27.4%) | 22 (26.5%) | |
| Open reduction | 151 (47.8%) | 104 (44.8%) | 47 (56.0%) | |
| Use of cerclage wires | 39 (12.3%) | 33 (14.2%) | 6 (7.1%) | |
| Post-op Mobilisation | FWB | 148 (46.9%) | 113 (48.7%) | 35 (41.7%) |
| (first 6 weeks) | PWB | 80 (25.3%) | 58 (25.0%) | 22 (26.2%) |
| TTWB | 51 (16.1%) | 41 (17.7%) | 10 (11.9%) | |
| NWB | 37 (11.7%) | 20 (8.6%) | 17 (20.2%) | |
| Surgical time (min) | 113.11 ± 45.56 | 111.32 ± 45.50 | 118.2 ± 45.62 | |
| Anaesthetic Time (min) | 47.66 ± 22.82 | 47.22 ± 22.76 | 48.91 ± 23.08 | |
| Time from induction to recovery (min) | 179.94 ± 50.26 | 177.57 ± 49.40 | 186.63 ± 52.34 | |
| Level of First Surgeon | ||||
| Registrar | 193 (61.5%) | 142 (61.2%) | 51 (62.2%) | |
| Consultant | 121 (38.5%) | 90 (38.8%) | 31 (37.8%) | |
| Level of Senior Surgeon Present | ||||
| Registrar | 178 (56.7%) | 131 (56.5%) | 47 (57.3%) | |
| Consultant | 136 (43.3%) | 101 (43.5%) | 35 (42.7%) | |
|
|
|
|
| |
| Nail complications | 78 (24.7%) | 34 (14.7%) | 44 (52.4%) | |
| Failure at lag screw junction | 24 (7.6%) | 1 (0.4%) | 23 (27.4%) | |
| Self-dynamisation | 20 (6.3%) | 5 (2.2%) | 15 (17.9%) | |
| Cut-out | 6 (1.9%) | 1 (0.4%) | 5 (6.0%) | |
| Nail infection | 5 (1.6%) | 3 (1.3%) | 2 (2.4%) | |
| Peri-implant fracture | 8 (2.5%) | 7 (3.0%) | 1 (1.2%) | |
| HAP/CAP | 46 (14.6%) | 35 (15.1%) | 11 (13.1%) | |
| UTI | 45 (14.2%) | 35 (15.1%) | 10 (11.9%) | |
| Wound infection | Superficial | 11 (3.5%) | 5 (2.2%) | 6 (7.1%) |
| Deep | 10 (3.2%) | 1 (0.4%) | 9 (10.7%) | |
| Washout/Revision for Infection | 6 (8.2%) | 2 (10.5%) | 4 (7.4%) | |
| CKD Stage pre-operatively | ||||
| Mild | 220 (71.2%) | 169 (74.4%) | 51 (62.2%) | |
| Moderate/Severe | 89 (28.8%) | 58 (25.6%) | 31 (37.8%) | |
| CKD Stage post-operatively | ||||
| Mild | 227 (74.4%) | 170 (76.2%) | 57 (69.5%) | |
| Moderate/Severe | 78 (25.6%) | 53 (23.8%) | 25 (30.5%) | |
| Pre-operative Transfusion | 25 (7.9%) | 21 (9.1%) | 4 (4.8%) | |
| Post-operative Transfusion (48 h) | 153 (48.6%) | 111 (47.8%) | 42 (50.6%) | |
| Post-operative Transfusion (total) | 192 (61.0%) | 138 (59.5%) | 54 (65.1%) | |
| Hb Drop (g/L) | 44.29 ± 18.24 | 44.13 ± 18.30 | 44.72 ± 18.20 | |
|
|
|
|
| |
| Adjusted Calcium | Normal | 181 (74.8%) | 141 (79.7%) | 40 (61.5%) |
| Low | 61 (25.2%) | 36 (20.3%) | 25 (38.5%) | |
| Albumin | Normal | 106 (38.4%) | 79 (38.7%) | 27 (37.5%) |
| Low | 170 (61.6%) | 125 (61.3%) | 45 (62.5%) | |
| Alkaline Phosphatase High | 55 (20.1%) | 40 (19.9%) | 15 (20.8%) | |
| Normal | 201 (73.7%) | 149 (74.1%) | 52 (72.2%) | |
| Low | 17 (6.2%) | 12 (6.0%) | 5 (6.9%) | |
| Phosphate Normal/High | 201 (82.4%) | 148 (83.1%) | 53 (80.3%) | |
| Low | 43 (17.6%) | 30 (16.9%) | 13 (19.7%) | |
| TSH | High | 13 (9.2%) | 9 (8.5%) | 4 (11.4%) |
| Normal | 126 (89.4%) | 95 (89.6%) | 31 (88.6%) | |
| Low | 2 (1.4%) | 2 (1.9%) | 0 (0.0%) | |
| Free T4 | High | 20 (14.4%) | 17 (16.2%) | 3 (8.8%) |
| Normal | 116 (83.5%) | 85 (81.0%) | 31 (91.2%) | |
| Low | 3 (2.1%) | 3 (2.9%) | 0 (0.0%) | |
| PTH | High | 62 (48.8%) | 47 (53.4%) | 15 (38.5%) |
| Normal | 65 (51.2%) | 41 (46.6%) | 24 (61.5%) | |
| Total 25OH Vitamin D Normal | 17 (12.1%) | 13 (12.7%) | 4 (10.3%) | |
| Low | 124 (87.9%) | 89 (87.3%) | 35 (89.7%) | |
|
|
|
|
| |
| Femoral Neck Shaft Angle | ||||
| Normal | 209 (67.4%) | 150 (65.8%) | 59 (72.0%) | |
| Coxa Valga | 89 (28.7%) | 70 (30.7%) | 19 (23.2%) | |
| Coxa Vara | 12 (3.9%) | 8 (3.5%) | 4 (4.9%) | |
| Number of fragments | Simple | 88 (28.0%) | 58 (25.0%) | 30 (36.6%) |
| (Comminution) | Moderate | 153 (48.8%) | 131 (56.5%) | 22 (26.8%) |
| Severe | 73 (23.2%) | 43 (18.5%) | 30 (36.6%) | |
| Isolated Subtrochanteric Extension | 49 (15.6%) | 33 (14.2%) | 16 (19.5%) | |
| Atypical | 20 (6.4%) | 7 (3.0%) | 13 (15.9%) | |
| Pathological | 11 (3.5%) | 7 (3.0%) | 4 (4.9%) | |
| Distal Extension | 123 (39.2%) | 91 (39.2%) | 32 (39.0%) | |
| Lesser Trochanter Fracture | 203 (64.6%) | 154 (66.4%) | 49 (59.8%) | |
| Medial Calcar Comminution | 21 (6.7%) | 16 (6.9%) | 5 (6.1%) | |
| Lateral Cortex Gap Size | ≤4 | 191 (60.4%) | 159 (68.5%) | 32 (38.1%) |
| (mm) | 5–9 | 85 (26.9%) | 48 (20.7%) | 37 (44.0%) |
| ≥10 | 40 (12.7%) | 25 (10.8%) | 15 (17.9%) | |
| Medial Cortex Gap Size | ≤4 | 210 (66.5%) | 166 (71.6%) | 44 (52.4%) |
| (mm) | 5–9 | 72 (22.8%) | 43 (18.5%) | 29 (34.5%) |
| ≥10 | 34 (10.7%) | 23 (9.9%) | 11 (13.1%) | |
| Anterior Cortex Gap Size | ≤4 | 201 (63.6%) | 156 (67.2%) | 45 (53.6%) |
| (mm) | 5–9 | 68 (21.5%) | 48 (20.7%) | 20 (23.8%) |
| ≥10 | 47 (14.9%) | 28 (12.1%) | 19 (22.6%) | |
| Posterior Cortex Gap Size | ≤4 | 231 (73.1%) | 185 (79.7%) | 46 (54.8%) |
| (mm) | 5–9 | 64 (20.2%) | 34 (14.7%) | 30 (35.7%) |
| ≥10 | 21 (6.7%) | 13 (5.6%) | 8 (9.5%) | |
| Reduction Angle Grouped | ||||
| (degrees) | Valgus 5–Varus 5 | 233 (73.7%) | 188 (81.0%) | 45 (53.6%) |
| Valgus >5 | 17 (5.4%) | 10 (4.3%) | 7 (8.3%) | |
| Varus 5–10 | 52 (16.5%) | 29 (12.5%) | 23 (27.4%) | |
| Varus >10 | 14 (4.4%) | 5 (2.2%) | 9 (10.7%) | |
| Anti-rotation Screw | 110 (35.6%) | 84 (37.0%) | 26 (31.7%) | |
| TAD | <25 | 259 (84.6%) | 193 (86.2%) | 66 (80.5%) |
| (mm) | ≥25 | 47 (15.4%) | 31 (13.8%) | 16 (19.5%) |
| Distal locking | 1 | 10 (3.2%) | 9 (3.9%) | 1 (1.2%) |
| (Number of Screws) | 2 | 306 (96.8%) | 223 (96.1%) | 83 (98.8%) |
| Method of locking | ||||
| Static Locking | 204 (64.8%) | 153 (66.2%) | 51 (60.7%) | |
| Secondary Dynamisation | 108 (34.3%) | 75 (32.5%) | 33 (39.3%) | |
| Dynamic | 3 (0.9%) | 3 (1.3%) | 0 (0.0%) | |
| Distance of tip of the nail from centre (AP) | ||||
| (mm) | −4 to 4 | 200 (63.7%) | 153 (66.5%) | 47 (56.0%) |
| Lateral ≥5 | 64 (20.4%) | 41 (17.8%) | 23 (27.4%) | |
| Medial ≥5 | 50 (15.9%) | 36 (15.7%) | 14 (16.7%) | |
| Distance of tip of the nail from centre (LAT) (mm) | ||||
| −4 to 4 | 256 (81.5%) | 186 (80.9%) | 70 (83.3%) | |
| Anterior ≥5 | 53 (16.9%) | 41 (17.8%) | 12 (14.3%) | |
| Posterior ≥5 | 5 (1.6%) | 3 (1.3%) | 2 (2.4%) | |
| Distance of tip of the nail from knee | ||||
| (mm) | <10 | 2 (0.6%) | 2 (0.9%) | 0 (0.0%) |
| 10 to 19 | 24 (7.6%) | 13 (5.7%) | 11 (13.1%) | |
| 20–29 | 99 (31.5%) | 78 (33.9%) | 21 (25.0%) | |
| ≥30 | 189 (60.3%) | 137 (59.6%) | 52 (61.9%) | |
| Nail/Canal Ratio | 0.82 ± 0.08 | 0.82 ± 0.08 | 0.83 ± 0.07 | |
|
|
|
|
| |
| HDU/ICU stay | 36 (11.4%) | 21 (9.1%) | 15 (17.9%) | |
| Total length of hospital stay (days) | 21.26 ± 19.19 | 20.74 ± 18.00 | 22.69 ± 22.22 | |
| Weekend admission | 105 (33.2%) | 76 (32.8%) | 29 (34.5%) | |
Dichotomous variables are presented as absolute numbers (percentages) of the positive event. Continuous variables are presented as mean (SD). ISS: Injury Severity Score; ASA: American Society of Anaesthesiologists Classification; DEXA: Dual-energy X-ray absorptiometry; FWB: Full Weight Bearing; PWB: Partial Weight Bearing; TTWB: Toe-touch weight bearing; NWB: Non-weight bearing; HAP: Hospital Acquired Pneumonia; CAP: Community Acquired Pneumonia; UTI: Urinary Tract Infection; CKD: Chronic Kidney Disease; DVT: Deep Vein Thrombosis; VTE: Venous Thromboembolism; TAD: Tip Apex distance; AP: Anterior-Posterior view; LAT: Lateral view; HDU: High Dependency Unit; ICU: Intensive Care Unit.
Unadjusted associations with progression to non-union.
|
|
|
| |
| Diabetes | 2.10 (1.07–4.13) | 0.031 | |
|
|
|
| |
| Post-op Mobilisation | FWB | Ref | Ref |
| (first 6 weeks) | PWB | 1.23 (0.66–2.28) | 0.522 |
| TTWB | 0.79 (0.358–1.73) | 0.553 | |
| NWB | 2.74 (1.30–5.81) | 0.008 | |
|
|
|
| |
| Nail complications | 6.41 (3.65–1.24) | <0.001 | |
| Failure at lag screw junction | 87.10 (11.54–657.56) | <0.001 | |
| Self-dynamisation | 9.87 (3.46–28.13) | <0.001 | |
| Cut-out | 14.62 (1.68–127.05) | 0.015 | |
| Wound infection | Superficial | 3.93 (1.16–13.27) | 0.028 |
| Deep | 29.48 (3.67–236.74) | 0.001 | |
| CKD Stage pre-operatively | |||
| Mild | Ref | Ref | |
| Moderate/Severe | 1.77 (1.04–3.03) | 0.037 | |
|
|
|
| |
| Adjusted Calcium | Normal | Ref | Ref |
| Low | 2.45 (1.32–4.55) | 0.005 | |
|
|
|
| |
| Number of fragments | |||
| (Comminution) | Moderate | Ref | Ref |
| Simple -Severe | 0.28 (0.16–0.49) | <0.001 | |
| Atypical | 6.06 (2.32–15.78) | <0.001 | |
| Lateral Cortex Gap Size | ≤4 | Ref | Ref |
| (mm) | ≥5 | 3.54 (2.10–5.96) | <0.001 |
| Medial Cortex Gap Size | ≤4 | Ref | Ref |
| (mm) | 5–9 | 2.54 (1.43–4.53) | 0.001 |
| ≥10 | 1.80 (0.82–3.98) | 0.144 | |
| Anterior Cortex Gap Size | ≤4 | Ref | Ref |
| (mm) | 5–9 | 1.44 (0.78–2.68) | 0.244 |
| ≥10 | 2.35 (1.20–4.60) | 0.012 | |
| Posterior Cortex Gap Size | ≤4 | Ref | Ref |
| (mm) | 5–9 | 3.55 (1.97–6.39) | <0.001 |
| ≥10 | 2.48 (0.97–6.32) | 0.058 | |
| Reduction Angle Grouped | |||
| (degrees) | Varus <5 | Ref | Ref |
| Varus 5–10 | 3.02 (1.61–5.65) | 0.001 | |
| Varus >10 | 6.85 (2.20–21.33) | 0.001 | |
|
|
| ||
| HDU/ICU stay | 2.18 (1.07–4.47) | 0.033 | |
OR: Odds Ratio; CI: Confidence Interval; FWB: Full Weight Bearing; PWB: Partial Weight Bearing; TTWB: Toe-touch weight bearing; NWB: Non-weight bearing; CKD: Chronic Kidney Disease; Ref: Reference.
Multivariate prediction models of non-union risk following a subtrochanteric fracture.
| A Model 1: Associations with progression to non-union, including self-dynamisation; OR: Odds Ratio | |||||
|
|
|
|
|
|
|
| Diabetes | 5 | 0.79 | 0.45 | 2.20 (0.92–5.25) | 0.077 |
| Self-dynamisation | 20 | 3.03 | 0.63 | 20.74 (6.09–70.68) | <0.001 |
| Wound infection (Deep) | 29 | 4.35 | 1.14 | 77.80 (8.26–732.71) | <0.001 |
| Degree of comminution | 11 | 1.62 | 0.37 | 5.05 (2.44–10.46) | <0.001 |
| Atypical | 11 | 1.59 | 0.58 | 4.92 (1.58–15.37) | 0.006 |
| Lateral Cortex Gap Size | 10 | 1.44 | 0.36 | 4.24 (2.12–8.50) | <0.001 |
| Reduction Angle | 7 | 1.01 | 0.42 | 2.75 (1.21–6.23) | 0.016 |
| Reduction Angle | 15 | 2.34 | 0.71 | 10.33 (2.59–41.26) | 0.001 |
| B Model 2: Associations witd progression to non-union, not including self-dynamisation; OR: Odds Ratio | |||||
|
|
|
|
|
|
|
| Diabetes | 6 | 0.70 | 0.42 | 2.02 (0.88–4.63) | 0.096 |
| Wound infection (Deep) | 35 | 3.97 | 1.12 | 53.05 (5.87–479.64) | <0.001 |
| Degree of comminution | 13 | 1.50 | 0.34 | 4.47 (2.29–8.74) | <0.001 |
| Atypical | 14 | 1.53 | 0.55 | 4.63 (1.58–13.56) | 0.005 |
| Lateral Cortex Gap Size | 11 | 1.21 | 0.32 | 3.37 (1.78–6.36) | <0.001 |
| Reduction Angle | 9 | 1.02 | 0.39 | 2.76 (1.30–5.88) | 0.008 |
| Reduction Angle | 20 | 2.27 | 0.70 | 9.71 (2.51–37.49) | 0.001 |
Figure 1ROC curve analysis of the multivariate prediction models. Model 1: including self-dynamisation. Model 2: excluding self-dynamisation. The discriminatory capability was similar in model 1 (including self-dynamisation; AUC = 0.831), and model 2 (excluding self-dynamisation; AUC = 0.790) was comparable. AUC: Area Under the Curve.
Figure 2Violin plot of the non-union scoring system (excluding self-dynamisation). A boxplot of the distribution has been included within the violin plot.
Non-union risk score and corresponding probability of non-union.
| Non-Union Risk Score | Probability of Non-Union |
|---|---|
| 0 | 4.0% |
| 6 | 7.6% |
| 9 | 10.3% |
| 13 | 15.2% |
| 14 | 16.7% |
| 15 | 18.3% |
| 19 | 26.0% |
| 20 | 28.2% |
| 22 | 33.0% |
| 23 | 35.5% |
| 26 | 43.5% |
| 27 | 46.3% |
| 28 | 49.1% |
| 33 | 62.8% |
| 35 | 67.9% |
| 36 | 70.3% |
| 39 | 76.8% |
| 41 | 80.6% |
| 42 | 82.3% |
| 44 | 85.3% |
| 47 | 89.0% |
| 48 | 90.1% |
| 54 | 94.7% |
| 63 | 98.0% |
| 100 * | 100.0% |
* Extrapolated value. A score of 100 was not observed in any of the patients.
Figure 3Probability curve of non-union according to score assigned (excluding self-dynamisation).